Shanmuga Hospital IPO Review: Apply or Avoid?

Posted by : sachet | Wed Feb 12 2025

Shanmuga Hospital IPO Review: Apply or Avoid?

Shanmuga Hospital IPO is now open for bidding on 13th February 2025. It is a fixed-price issue consisting of a fresh issue of 38,18,000 shares worth Rs 20.62 crore. The issue is going to be listed on BSE and SME on its tentative listing date, 20th February 2025. 

Shanmuga Hospital IPO

Shanmuga Hospital IPO date is fixed between 13th February 2025 and 17th February 2025. The face value of Shanmuga Hospital Limited shares stands at Rs 10 per share, and the IPO price is set at Rs 54. 

Integrated Registry Management Services Private Limited is the registrar of Shanmuga Hospital IPO, responsible for managing the allotment process and refund initiation procedure in the IPO. Download Shanmuga Hospital IPO RHP to get more details on the IPO. 

Shanmuga Hospital IPO Details

IPO Open Date13th February 2025
IPO Close Date17th February 2025
IPO Allotment Date18th February 2025
Refund Initiation 19th February 2025
Issue Size38,18,000 shares (worth Rs 20.62 crore) 
Face ValueRs 10 per share
Lot Size2,000 shares
IPO Price Rs 54
Market Makers Portion1,92,000 shares
Issue TypeFixed Price Issue 
Listing AtBSE & SME
Listing Date20th February 2025

Shanmuga Hospital IPO GMP and Key Details

Shanmuga Hospital IPO is entirely a fresh issue of 38,18,000 shares worth Rs 20.62 crore. Shanmuga Hospital Limited shares will be listed on BSE and SME. Furthermore, the SEBI has specified the share reservation criteria for different investors’ categories. Explore it in the below table. 

Investor CategoriesReservation Required 
QIB<50% of total issue
Retail Investors>35% of total issue
NII (sNII+bNII)>15% of total issue
Total100%

Note: QIB (Qualified Institutional Buyers), NII (Non-Institutional Investors), sNII (Small Non-Institutional Investors), bNII (Big Non-Institutional Investors). 

Shanmuga Hospital IPO GMP Grey Market Premium

GMP is the difference between the fixed price of the issue and the price at which company shares are trading in the grey market. Want to get live updates on Shanmuga Hospital IPO GMP? If yes, then you’ve reached the right place. Have a look at the table below to learn about the GMP trends of Shanmuga Hospital IPO.

GMP DateGMP Estimated Listing Price Estimated Listing Gains
12-02-2025Rs 8Rs 6214.81%
11-02-2025Rs 8Rs 6214.81%
10-02-2025Rs 8Rs 6214.81%
09-02-2025Rs 0Rs 540.00%
08-02-2025Rs 0Rs 540.00%

*Data is updated as of 12th February 2025.

As of now, on 12th February 2025, Shanmuga Hospital IPO GMP stands at Rs 8 per share, which means the share will likely be listed at Rs 62 (54+8) on its tentative listing date, 20th February 2025. 

GMP data is subject to change based on market sentiments. You must check the live GMP status before applying for Shanmuga Hospital IPO. Stay informed with Univest to know about live updates on IPOs and their GMP trends. 

Shanmuga Hospital IPO Review

Look at the detailed review of Shanmuga Hospital IPO for a deep understanding of its potential to deliver listing gains on 20th February 2025. The Shanmuga Hospital IPO review provided below will also assist you in investing effectively to avoid significant losses in the Indian stock market. Explore to make an informed investment decision on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the growth margins and declines of the business financials before applying for any IPO.

The revenue of Shanmuga Hospital Limited stood at Rs 39.50 crore, which increased by 9.84% to Rs 43.39 crore. On the other hand, the PAT of the company was raised by 10.50% from Rs 4.76 crore to Rs 5.26 crore.

Shanmuga Hospital Limited has shown a consistent increase in net worth, indicating that the company has robust growth potential for the coming decades. However, the brokers, experts, RAs, and investors have a positive outlook for Shanmuga Hospital IPO for its tentative listing day, which is 20th February 2025.  

Technical Analysis

Many technical parameters are available to assess the potential of a stock to deliver returns. To analyse the technicals of Shanmuga Hospital IPO, use the indicators tabulated below.

Key IndicatorsValue
PE Ratio (Price-to-Earnings) 10.05
PB Ratio (Price-to-Book)3.09
EPS (Earnings Per Share)5.37
RoNW30.71%
ROE30.71%
ROCE35.89%
PAT Margin (Profit After Tax)12.13
Market CapitalisationRs 73.51 crore

*Data is updated as of 12th February 2025. 

The PE ratio of Shanmuga Hospital Limited shares is 10.05, and its Earnings Per Share stands at 5.37. This indicates that the Shanmuga Hospital IPO can potentially deliver short-term and long-term returns. 

Shanmuga Hospital Limited Peer Comparison

Company NameRevenue (in cr.)PE RatioFace Value (in Rs)EPS (in Rs)RoNW (in %)Dividend YieldNAV (in Rs)
Shanmuga Hospital Limited43.3910.05105.3730.71%N/A17.49
Family Care Hospitals Limited4.24-0.9710-6.1721.50%0.00%2.67
Aashka Hospitals Limited6.04100.74101.0114.07%0.00%41.16
Asarfi Hospital Limited44.0842.73102.1119.16%0.00%35.78
Max Healthcare Institute Limited1,420.0898.401010.3712.58%0.15%90.51
Fortis Healthcare Limited1,796.1060.401010.19-5.48%0.16%103.94
Global Health Limited825.5376.41214.6112.14%0.00%113.50
Sygene International Limited933.2858.051012.4617.28%0.17%109.20

*Data is updated as of 12th February 2025. 

Note: The data as mentioned above is taken from authentic sources and highlights pre-issue information. PE ratio and EPS of Shanmuga Hospital Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

IndicatorsPre-IPOPost-IPO
PE Ratio10.0511.36
EPS 5.374.75

*Data is updated as of 12th February 2025. 

Shanmuga Hospital IPO Subscription Status

Shanmuga Hospital IPO is now open for bidding on 13th February 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Shanmuga Hospital IPO Subscription Status

Investor CategoryShares OfferedShares SubscribedSubscription in Times
Retail InvestorsYet to be announcedYet to be announcedYet to be announced
QIBYet to be announcedYet to be announcedYet to be announced
NII (sNII+bNII)Yet to be announcedYet to be announcedYet to be announced
Market Maker1,92,000Yet to be announcedYet to be announced
TotalYet to be announcedYet to be announcedYet to be announced

*Data is updated as of 12th February 2025.

About Shanmuga Hospital Limited

Shanmuga Hospital Limited was incorporated in 2020 and is recognised as a multispecialty hospital. The hospital is equipped with advanced healthcare technology and a capacity of 151 beds. Moreover, the company has received accreditation from NABH and NABL. It offers high-quality services in the Indian healthcare industry. 

It is located in Salem, Tamil Nadu with a span of 45,311 square feet across two different blocks and three floors. Shanmuga Hospitals Limited offers IPD and OPD services with skilled and dedicated team members. 

Shanmuga Hospital Limited Financials

Before applying for Shanmuga Hospital IPO, the company’s financial analysis is essential. Look at the table to learn about Shanmuga Hospital Limited’s financials. 

Year Ended30th September 2024 (in cr.)31st March 2024 (in cr.)31st March 2023 (in cr.)31st March 2022 (in cr.)
Assets36.5333.9223.0510.65
Revenue24.8343.3939.5041.47
Profit After Tax2.395.264.766.72
Reserves and Surplus9.737.3411.746.98
Debt9.769.027.65
Net Worth19.5317.1311.827.06

*Data is updated as of 12th February 2025. 

Explanation

Shanmuga Hospital Limited has shown a growth of 9.84% in its revenue, estimated at Rs 39.50 crore in  March 2022 and Rs 43.39 crore in March 2023. Moreover, the PAT of the company was raised by 10.50% from Rs 4.76.28 crore to Rs 5.26 crore. 

Shanmuga Hospital IPO Bidding Requirements

Shanmuga Hospital IPO has reserved minimum or maximum lot sizes to be applied by different investor categories. Explore the table below to learn about the bidding requirements to be fulfilled for applying for this IPO. 

Investor CategoryLotsSharesAmount (in Rs)
Retail (Minimum)12,000 sharesRs 1,08,000
Retail (Maximum)12,000 sharesRs 1,08,000
HNIs (Minimum)24,000 sharesRs 2,16,000

Aim of Shanmuga Hospital IPO

The primary aim of Shanmuga Hospital IPO is to raise Rs 20.62 crores. However, the company has decided to utilise these funds in multiple practices. Some of the secondary objectives behind Shanmuga Hospital IPO are mentioned below.

  • Meet capital expenditure of the company for purchasing medical equipment. 
  • General corporate purposes. 

Should I Invest in Shanmuga Hospital IPO?

“Shanmuga Hospital Limited is operating in a highly fragmented and competitive segment. According to the current financial position of Shanmuga Hospital Limited, the issue appears to be aggressively priced” ~ Dilip Davda (Chief Editor at Chittorgarh)

Explore the pros and cons of Shanmuga Hospital IPO to make an informed investment decision. These pros and cons will likely help you understand the IPO’s efficiency in delivering profits in the coming years. 

Pros of Shanmuga Hospital IPO

  • Oncology Presence
  • Specialised Equipment (LINAC, CATHLAB, MRI, MODULAR OT)
  • Tie-Up with Government and Private Organisations. 

Cons of Shanmuga Hospital IPO

  • High lot size

How to Apply for Shanmuga Hospital IPO?

Check the steps mentioned below to apply for Shanmuga Hospital IPO

  • Step 1: Conduct thorough research on Shanmuga Hospital IPO GMP, subscription status, issue size, lot size, and other key details. 
  • Step 2: Open a demat account on Univest to learn about real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
  • Step 3: Bid for one lot of 2,000 shares worth Rs 1,08,000 of Shanmuga Hospital IPO.   
  • Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for Shanmuga Hospital IPO from more than one demat account to increase your allotment chances. 

How to Check Shanmuga Hospital IPO Allotment Status?

You can check your Shanmuga Hospital IPO allotment in different ways. These include BSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.

Check On BSE

  • Visit the BSE’s Official Website
  • Navigate to the IPO allotment section.
  • Select Equity as the issue type. 
  • Choose Shanmuga Hospital IPO.  
  • Choose whether to proceed with the PAN number or application number.
  • Submit your details to get the allotment status online. 

Check On the Registrar Portal

  • Visit the registrar portal
  • Click on the allotment option.
  • Fill in the required details.
  • Click on the submit button to know your Shanmuga Hospital IPO allotment status.

Let’s Wrap

Shanmuga Hospital IPO is the fixed price issue of 38,18,000 shares worth Rs 20.62 crores. It is entirely a fresh issue. The shares of Shanmuga Hospital Limited will be listed on BSE and SME on its tentative listing date of 20th February 2025. Researching Shanmuga Hospital IPO GMP and reviews are highly recommended to book your ideal listing gains. Brokers and investors have a positive outlook for this IPO and highlighted its pros and cons. Benefits of this IPO include oncology presence, specialised equipment, and government support. 

Open a demat account on Univest now to initiate your investment journey. Explore the Univest terms and conditions by clicking on the link

FAQs on Shanmuga Hospital IPO

How is Shanmuga Hospital IPO?

Ans. Currently, on 12th February 2025, Shanmuga Hospital IPO GMP (Grey Market Premium) stands at Rs 8 (14.81% up). It indicates that the estimated listing price could be Rs 62 per share. It is an offer for sale of 38,18,000 shares worth Rs 20.62 crore. The IPO price is fixed at Rs 54 per share, and the face value of each share is Rs 10. 

What is Shanmuga Hospital IPO price?

Ans. Shanmuga Hospital IPO price has been set at Rs 54 per share. Retail investors can apply for a minimum and maximum of 1 lot consisting of 2,000 shares worth Rs 1,08,000. Moreover, HNIs are required to bid for a minimum of 2 lots (2,000 shares) worth Rs 2,88,000. 

Is Shanmuga Hospital IPO good?

Ans. During FY2023-24, the revenue of Shanmuga Hospital Limited was increased by 9.84% to reach Rs 43.39 crore. On the other hand, the PAT of the company was raised by 10.50% from Rs 4.76 crore to Rs 5.26 crore. Shanmuga Hospital IPO has gained a positive rating from industry experts, brokers and institutional investors.

Who is the registrar of Shanmuga Hospital IPO?

Ans. Integrated Registry Management Services Private Limited is the registrar of Shanmuga Hospital IPO, awaiting to manage the allotment and refund initiation procedures of the issue. For any query regarding Shanmuga Hospital IPO allotment and refund, you can contact Integrated Registry Management Services Private Limited at einward@integratedindia.in or 044-28140801. 

What is the issue size of Shanmuga Hospital IPO? 

Ans. Shanmuga Hospital IPO is the fixed price issue for 38,18,000 shares worth Rs 20.62 crore. It is a fresh issue of 38,18,000 shares open on 12th February 2025 and will be closed on 14th February 2025. 

Disclaimer: The above information is accumulated from authentic sources and is just for informational purposes. To have detailed information about Shanmuga Hospital IPO, download the Shanmuga Hospital IPO RHP and Shanmuga Hospital IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Read Other Popular Articles from Univest

Best Multibagger Stocks For Next 5 Years in India

FMCG Sector Stocks to Invest in India

Best Fundamentally Strong Stocks For Long Term

Top Green Energy Stocks in Buy In 2025 

Fundamentally Strong Stocks In BSE 

Solar Penny Stocks in India 2025

Top 10 Fundamentally Strong Penny Shares to Buy in 2025

Explore Current and Previous IPOs

CompanyOpening Date Closing Date
Volar Car Limited12th February 202514th February 2025
Maxvolt Energy Limited12th February 202514th February 2025
Hexaware Technologies Limited12th February 202514th February 2025
Chandan Healthcare Limited10th February 202512th February 2025
Ajax Engineering Limited10th February 202512th February 2025
Eleganz Interiors Limited7th February 2025 11th February 2025
Readymix Construction Machinery Limited6th February 2025 10th February 2025
Solarium Green Energy Limited6th February 2025 10th February 2025
Amwill Healthcare Limited 5th February 2025 7th February 2025 

Univest Screeners

ExclusiveIndicesBreakouts
Buy in Short TermNifty Small Cap 100Daily Fresh Breakouts
Buy in Long TermNifty MidcapWeekly Breakouts
FII Holdings ChangeNifty BankOversold Stocks
Golden CrossoverSensexNearing Breakout
Upcoming DividendsNifty Fin Service
DII Holdings ChangeBankex
High Dividend StocksNifty Mid Cap 100
Earnings AnnouncedNifty 50
Fundamentally Strong 
Top Gainers
Top Losers
Low Debt Mid Caps
Cash-Rich Small Caps
Volume Shockers
52-Week High 
52-Week Low

52-Week Low Stocks Today

Stocks LTP (₹)New Low (₹)
Life Insurance Corporation of India Limited799.80790.20
Tata Motors Limited677.75675.10
Coal India Limited359.50357.50
Varun Beverages Limited520.35511.15
Indian Oil Corporation Limited120.47120.00
GAIL India Limited161.69160.73
Swiggy Limited333.35330.00
Godrej Properties Limited2,025.952,012.00
Tube Investments of India Limited2,739.602,718.60
MRF Limited1,08,716.451,08,716.45
Procter & Gamble Hygiene and Health Care Limited13,933.4013,841.00
Tata Communications Limited1,525.351,513.25
Aditya Birla Capital Limited160.62160.00
Steel Authority of India Limited100.0299.50
Container Corporation of India Limited692.45687.05
Thermax Limited3,165.303,103.00
Honeywell Automation India Limited36,319.2536,101.00
Astral Limited 1,415.151,405.05
Gujarat Gas Limited421.25420.00
Ola Electric Mobility Limited65.2664.36
The New India Assurance Company Limited164.34163.00
Star Health and Allied Insurance Company Limited399.60397.85
Mother Sumi Wiring India Limited51.8151.30
Tata Chemicals Limited883.05878.05
Vedant Fashions Limited894.70879.00
Emcure Pharmaceuticals Limited1,110.801,087.35
Delhivery Limited284.15283.05
Bayer CropScience Limited4,787.804,780.50
Brainbees Solutions Limited418.35407.30
Mangalore Refinery and Petrochemicals Limited117.63116.65

*Data is updated as of 11th February 2025. 

52 Week High Stocks Today

 

Stocks LTP (₹)New High  (₹)
Kotak Mahindra Bank Limited1,918.601,970.50
Camlin Fine Science Ltd. 259.87272.00
Indo Thai Securities Limited2,051.402,200.15

*Data is updated as of 11th February 2025. 

Popular Stocks to Consider

 

Stock NameNSE Symbol 
Abbott India Ltd.ABBOTINDIA
Adani Total Gas Ltd.ATGL
Aegis Logistics Ltd.AEGISLOG
Apollo Hospitals Enterprise Ltd.APOLLOHOSP
Apollo Tyres Ltd.APOLLOTYRE
Ashok Leyland Ltd.ASHOKLEY
AU Small Finance Bank Ltd.AUBANK
Aurobindo Pharma Ltd.AUROPHARMA
Axis Bank Ltd.AXISBANK
Bajaj Auto Ltd.BAJAJAUTO
Bajaj Finance Ltd.BAJAJFINANCE
Balkrishna Industries Ltd.BALKRISIND
Bank of Baroda Ltd.BANKBARODA
Biocon Ltd.BIOCON
Brigade Enterprises Ltd.BRIGADE
Britannia Industries Ltd.BRITANNIA
Canara Bank Ltd.CANBK
Castrol India LtdCASTROLIND
Cholamandalam Investment and Finance Company Ltd.CHOLAFIN
Coforge Ltd.COFORGE
Den Networks Ltd.DEN
Dish TV India Ltd.DISHTV
Divis Laboratories Ltd.DIVISLAB
Dr Reddy’s Laboratories Ltd.DRREDDY
Eicher Motors Ltd.EICHERMOT
Exide Industries Ltd.EXIDEIND
Federal Bank Ltd.FEDERALBNK
GAIL (India) Ltd.GAIL
Gland Pharma Ltd.GLAND
Glenmark Pharmaceuticals Ltd.GLENMARK
Godrej Consumer Products Ltd.GODREJCP
Godrej Properties Ltd.GODREJPROP
Granules India Ltd.GRANULES
Gujarat Gas Ltd.GUJGASLTD
Gujarat State Petronet Ltd.GSPL
Hathway Cable & Datacom Ltd.HATHWAY
HCL Technologies Ltd.HCLTECH
HDFC Assets Management Company Ltd.HDFCAMC
Hero MotoCorp Ltd.HEROMOTOCO
Hindustan Petroleum Corporation Ltd.HINDPETRO
ICICI Bank Ltd.ICICIBANK
ICICI Lombard General Insurance Company Ltd.ICICIGI
ICICI Prudential Life Insurance Company Ltd.ICICIPRULI
IDFC First Bank Ltd.IDFCFIRSTB
Indian Oil Corporation Ltd.IOC
Infosys Ltd.INFY
IPCA Laboratories Ltd.IPCALAB
J.B. Chemicals & Pharmaceuticals Ltd.JBCHEPHARM
Kotak Mahindra Bank Ltd.KOTAKBANK
L&T Technology Services Ltd.LTTS
Laurus Labs Ltd.LAURUSLABS
LIC Housing Finance Ltd.LICHSGFIN
LTI Mindtree Ltd.LTIM
Lupin Ltd.LUPIN
Macrotech Developers Ltd.LODHA
Mahangar Gas Ltd.MGL
Mahindra & Mahindra Ltd.M&M
Mahindra Lifespace Developers Ltd.MAHILIFE
Mankind Pharma Ltd.MANKIND
Marico Ltd.MARICO
Metropolis Healthcare Ltd.METROPOLIS
Mphasis Ltd.MPHASIS
MRF Ltd.MRF
Muthoot Finance Ltd.MUTHOOTFIN
NATCO Pharma Ltd.NATCOPHARM
Nazara Technologies Ltd.NAZARA
Nestle India Ltd.NESTLEIND
Oberoi Realty Ltd.OBEROIRLTY
Persistent Systems Ltd.PERSISTENT
Petronet LNG Ltd.PETRONET
Phoenix Mills Ltd.PHOENIXLTD
Power Finance Corporation Ltd.PFC
Prestige Estates Projects Ltd.PRESTIGE
Procter & Gamble Hygiene & Health Care Ltd.PGHH
Punjab National Bank Ltd.PNB
PVR INOX Ltd.PVRINOX
Radico Khaitan Ltd.RADICO
Raymond Ltd.RAYMOND
Saregama India Ltd.SAREGAMA
SBI Cards and Payment Services Ltd.SBICARD
SBI Life Insurance Company Ltd.SBILIFE
Sobha Ltd.SOBHA
State Bank of India Ltd.SBIN
Sun TV Network Ltd.SUNTV
Syngene International Ltd.SYNGENE
Tata Consultancy Services Ltd.TCS
Tata Consumer Products Ltd.TATACONSUM
Tata Motors Ltd.TATAMOTORS
Tech Mahindra Ltd.TECHM
Tips Music Ltd.TIPSMUSIC
Titan Company LimitedTITAN
Torrent Pharmaceuticals Ltd.TORNTPHARM
United Breweries Ltd.UBL
United Spirits Ltd.UNITDSPR
Varun Beverages Ltd.VBL
Wipro Ltd.WIPRO
Yes Bank LimitedYESBANK
Zee Entertainment Enterprises Ltd.ZEEL
Zomato LimitedZOMATO
Zydus Lifesciences Ltd.ZYDUSLIFE

icon

100% Safe & Secure Platform.

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright

2025 Univest. All rights reserved. | Designed with ❤️ in India
About Univest
About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
 
Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
 
Univest Stock Broking Disclosures
Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
 Risk Disclosures on Derivatives
1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
2. On an average, loss makers registered net trading loss close to ₹ 50,000
3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
Investors are further cautioned to avoid practices like:
a. Sharing 
i) trading credentials – login id and passwords including OTPs.
ii) trading strategies,
iii) position details.
b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
 Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
arrow down